Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2024 Earnings Call Transcript February 13, 2025
Blueprint Medicines Corporation misses on earnings expectations. Reported EPS is $-0.79 EPS, expectations were $-0.68.
Operator: Good morning. My name is Nadia, and I’ll be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines 4Q and FY 2024 Earnings Release and Conference Call. [Operator Instructions]. Cassie Saitow, you may begin your...
